Predicting MHC-I ligands across alleles and species: how far can we go?
Abstract Background CD8+ T-cell activation is initiated by the recognition of epitopes presented on class I major histocompatibility complex (MHC-I) molecules. Identifying such epitopes is useful for molecular understanding of cellular immune responses and can guide the development of personalized v...
Saved in:
| Main Authors: | Daniel M. Tadros, Julien Racle, David Gfeller |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Genome Medicine |
| Online Access: | https://doi.org/10.1186/s13073-025-01450-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Asthma treatable traits: How far do we have to go?
by: Honglei Shi, et al.
Published: (2025-04-01) -
Reflections on how far Brazil can go with Financial Education in Basic Education
by: Celso Ribeiro Campos, et al.
Published: (2024-08-01) -
Reproducibility and transparency: what’s going on and how can we help
Published: (2025-01-01) -
Severe complications in pediatric B-Cell ALL: How far should we go in escalating care?
by: Kezia Imanuella Godam, et al.
Published: (2025-06-01) -
How Low Can Q Go?
by: John C. Forbes
Published: (2025-01-01)